Peptable

Comparison

CJC-1295 vs Kisspeptin

Function

While CJC-1295 is used in research to chronically elevate endogenous growth hormone and IGF-1 levels, enabling studies of body composition, metabolic, and anti-aging effects of prolonged GH exposure10, Kisspeptin is a key regulator of the hypothalamic–pituitary–gonadal axis, controlling puberty and fertility; kisspeptin-10 also inhibits trophoblast invasion and tumor metastasis in experimental models339199.

Mechanism

While CJC-1295 works as a tetrasubstituted 29-amino-acid analog of GHRH(1–29) that acts as a potent agonist at the GHRH receptor and, in its DAC form, covalently binds serum albumin to extend half-life from minutes to days, resulting in sustained pulsatile GH and IGF-1 increase1082, Kisspeptin is a family of peptides (eg, kisspeptin-10, -13, -14, -54) derived from the KISS1 precursor that activate G-protein–coupled receptor KISS1R (GPR54), triggering GnRH release and regulating pubertal onset and reproductive axis activity339199.

Receptor

CJC-1295

Growth hormone–releasing hormone receptor (GHRHR) on anterior pituitary somatotrophs1094103

Kisspeptin

KISS1R (GPR54) kisspeptin receptor33919943

Organism or Origin

CJC-1295

Synthetic peptide based on human hypothalamic GHRH10120

Kisspeptin

Endogenous human peptide products of the KISS1 gene9199

Gene

CJC-1295

GHRH

Kisspeptin

KISS1

Summary

Both peptides fall into a similar broad context as Hormone peptides, although the details of how they are used and discussed still diverge. Their typical research and application settings separate fairly clearly: CJC-1295 is more often discussed in the realm of Metabolic and endocrine and Aging and longevity, whereas Kisspeptin is more often associated with the realm of Reproductive health. Both appear to work through Receptor agonist, but the functional emphasis still separates, with CJC-1295 leaning toward Anabolic growth, Lipolysis and fat loss, and Metabolic regulation and Kisspeptin leaning toward . CJC-1295 has a more synthetic analog origin, while Kisspeptin is closer to natural endogenous background and both are still best understood as being in Preclinical development. CJC-1295 takes the form of a peptide conjugate, whereas Kisspeptin is closer to a linear peptide, while CJC-1295 carries d-amino acid substitution features, while Kisspeptin instead reflects amidation changes.

Sources

10CJC-1295: Long-Acting GHRH Analog - Alpha Carbon Labs, https://alphacarbonlabs.com/blog/cjc-1295-long-acting-ghrh-analog
82CJC-1295 no DAC 5mg (Mod GRF 1-29), https://www.peptidesciences.com/mod-grf-1-29-5mg-cjc-1295-no-dac
94Growth-hormone-releasing hormone receptor - Wikipedia, https://en.wikipedia.org/wiki/Growth-hormone-releasing_hormone_receptor
103Growth-hormone-releasing hormone receptor - Wikipedia, https://en.wikipedia.org/wiki/Growth_hormone_releasing_hormone_receptor
120Growth hormone–releasing hormone - Wikipedia, https://en.wikipedia.org/wiki/Growth_hormone%E2%80%93releasing_hormone
70Kisspeptin-10, rat, https://pubchem.ncbi.nlm.nih.gov/compound/Kisspeptin-10_-rat
91Kisspeptin - Wikipedia, https://en.wikipedia.org/wiki/Kisspeptin
99Kisspeptin-1 - an overview, https://www.sciencedirect.com/topics/biochemistry-genetics-and-molecular-biology/kisspeptin-1